Basiliximab

ATC L04AC02 · 10 markets · 17 records

Basiliximab 10 markets · 17 records Forms

GB 4 records · 2 strengths

20 mginjectionSimulect 20mg powder and solvent for solution for injection vials+1Simulect 20mg powder for solution for injection vials also in AU·CN
10 mginjectionSimulect 20mg powder and solvent for solution for injection vials+1Simulect 20mg powder for solution for injection vials

US 3 records · 2 strengths

10 mg/2.5 mLinjectionSimulect+1__no_trade__
20 mg/5 mLinjectionSimulect

AU 3 records · 3 strengths

20 mginjectionSIMULECT basiliximab (rmc) 20mg powder for injection vial also in GB·CN unknown
20 mgunknownSIMULECT basiliximab (rmc) 20mg powder for injection vial and diluent ampoule unknown

Records without a stated strength · 1 Simulect

CA 1 records · 1 strengths

20 mgpowderSimulect

SG 1 records · 1 strengths

20 mg/vialinjectionSIMULECT FOR INJECTION 20 mg/vial

CN 1 records · 1 strengths

20 mginjection舒莱巴利昔单抗 also in GB·AU

TW 1 records · 1 strengths

4 mginjectionSIMULECT LYOPHILISATE FOR INJECTION 4MG/ML+1新睦樂凍晶注射劑

HK 1 records · 1 strengths

Records without a stated strength · 1 SIMULECT POWDER FOR INJ 20MG

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 Simulect

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.